DATE/TIME
September 18, 11:20 – 12:00 PM EST
TITLE
The Future of Pharma Partnerships: Key Trends Shaping BD and Alliance Management
SPEAKERS
Navdeep Pahuja
Senior Director of Business Development and M&A
Dr. Reddy’s Laboratories
Mayank Nagar
Vice President and Head, Strategic Alliance Management & Tech Services, North America Generics
Dr. Reddy’s Laboratories
ABSTRACT
Dr. Reddy’s experts will explore how evolving market dynamics, digital transformation, and patient-centric innovation are redefining the way pharmaceutical companies collaborate. Key themes include the rise of data-driven decision-making in business development, the growing importance of agile and cross-functional alliance models, and the strategic shift toward ecosystem partnerships that go beyond traditional licensing. Attendees will gain insights into how forward-thinking organizations are leveraging technology, trust, and transparency to build resilient, value-driven partnerships in an increasingly complex global landscape.
BIO
Mayank Nagar is a seasoned pharmaceutical professional with over 25 years of global leadership experience spanning pharma operations, consulting, compliance, and quality management systems. He has worked with leading pharmaceutical corporations and advisory firms, delivering strategic solutions to a diverse range of clients—including innovators, generic manufacturers, biopharmaceutical companies, startups, and global health organizations. His expertise includes enabling new product launches, assessing technical and business risks, developing operational strategies, and navigating regulatory challenges to achieve business objectives.
In his current role, Mayank also leads Strategic Alliance Management, where he plays a pivotal role in fostering high-impact partnerships and driving collaborative value creation across the pharmaceutical ecosystem. Mayank is recognized for his strong liaison and analytical skills, with a proven ability to thrive in multicultural environments. He has successfully led cross-cultural initiatives across India, the U.S., Ireland, Romania, Brazil, South Africa, and Malaysia.
Combining deep technical knowledge with sharp business acumen, Mayank is well-versed in global quality regulations and has guided teams through numerous successful U.S. FDA and EU inspections. His experience spans a wide array of pharmaceutical dosage forms, including drug-device combination products, sterile liquids and dry powders, complex solid orals, semisolids, sublingual films, patches, and inhalation products. He also brings significant expertise in business due diligence, having conducted audits to support multiple mergers and acquisitions.
